SCHEMBL13477348

SCHEMBL13477348

CCCCCCC/C(=N\C)NC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MAPT P10636 1/20 0.46
CES2 O00748 3/20 0.45
CES1 P23141 3/20 0.45
HSP90AA1 P07900 1/20 0.44
GPR84 Q9NQS5 7/20 0.43
PPARG P37231 7/20 0.43
PPARD Q03181 7/20 0.43
PPARA Q07869 7/20 0.43
HDAC11 Q96DB2 5/20 0.43
TSHR P16473 5/20 0.43
PTPN1 P18031 3/20 0.43
ALDH1A1 P00352 3/20 0.43
TLR2 O60603 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
FABP4 P15090 2/20 0.43
SLC22A6 Q4U2R8 1/20 0.43
SLC22A8 Q8TCC7 1/20 0.43
MEN1 O00255 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29147871 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL3387043 0.75 CES2 (0.41) KMT2ACES2CES1HSP90AA1GPR84
SCHEMBL9410605 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL3387041 0.75 CES2 (0.41) KMT2ACES2CES1HSP90AA1GPR84
SCHEMBL20724956 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL9410595 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL27620682 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL19350672 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL1573059 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1
SCHEMBL26908779 0.75 HSP90AA1 (0.61) KMT2AKDM4EMAPTCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES MSD K.K. (JP) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041660-A1 NOVEL 2-PYRIDINECARBOXAMIDE DERIVATIVES GCKR, GCK, HK2 KMT2A 1297/4885KDM4E 1304/4885MAPT 4596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.